Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 68, Status: Authorised
HMPC: overview of assessment work - priority list
EMA decision on adoption by analogy of Commission decision C (2025) 2495
Human medicines European public assessment report (EPAR): Protopic, tacrolimus, Date of authorisation: 27/02/2002, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Revision: 1, Status: Authorised
Keeping medicines safe: Reporting side effects can make medicines safer for everyone
Safety of medicines
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 April 2026, 15:00 (CEST) to 16 April 2026, 16:00 (CEST)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 May 2026, 15:00 (CEST) to 13 May 2026, 16:00 (CEST)
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2026, 15:00 (CET) to 10 February 2026, 16:00 (CET)